Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print January 17, 2007
DOI: 10.2337/db06-0322

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db06-0322v1
56/4/1095    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, Z.
Right arrow Articles by Björklund, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, Z.
Right arrow Articles by Björklund, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Effects of diazoxide on gene expression in rat pancreatic islets are largely linked to elevated glucose and potentially serve to enhance beta cell sensitivity

Zuheng Ma1, Neil Portwood1, David Brodin2, Valdemar Grill1,3, and Anneli Björklund1

1Endocrine and Diabetes Unit, Department of Molecular Medicine and Surgery, Karolinska Hospital, Karolinska Institutet, S-171 76 Stockholm, Sweden
2Dept. of Biosciences, NOVUM, 14157 Huddinge, Sweden
3Endocrine Unit, Dept. of Abdominal Diseases, St. Olav's University Hospital, Norwegian University of Science and Technology, N-7006 Trondheim, Norway

Correspondence: anneli.bjorklund{at}ki.se

Diazoxide enhances glucose-induced insulin secretion from beta cells through mechanisms which are not fully elucidated. Here we used microarray analysis (Affymetrix) to investigate effects of diazoxide. Pancreatic islets were cultured overnight at 27 or 11 or 5.5 mmol/l glucose ± diazoxide. Inclusion of diazoxide up-regulated altogether 211 genes (signal log2 ratio ≥0.5) and down-regulated 200 genes (signal log2 ratio≤-0.5). 92 % of diazoxide's effects (up- and downregulation) were observed only after co-culture with 11 or 27 mmol/l glucose. At 11 mM diazoxide up-regulated 97 genes and down-regulated 21 genes. Increasing the glucose concentration to 27 mmol/l markedly shifted these proportions toward down-regulation (101 genes up- regulated, 160 genes down-regulated). At 27 mmol/l glucose most genes down-regulated by diazoxide were oppositely affected by glucose (80%). Diazoxide influenced expression of several genes central to beta cell metabolism. Diazoxide down-regulated genes of fatty acid oxidation, up-regulated genes of fatty acid synthesis and down-regulated uncoupling protein 2 and lactic acid dehydrogenase, Diazoxide up-regulated certain genes known to support ß-cell functionality, such as nkx6.1 and pdx 1. - Long term elevated glucose is permissive for most of diazoxide's effects on gene expression, the proportion of effects shifting to down-regulation with increasing glucose concentration. Effects of diazoxide on gene expression could serve to enhance ß-cell functionality during continuous hyperglycemia.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.